- Home
- BORR vs RXST Comparison
BORR vs RXST Comparison
Compare BORR & RXST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BORR
- RXST
- Stock Information
- Founded
- BORR 2016
- RXST 1997
- Country
- BORR Bermuda
- RXST United States
- Employees
- BORR N/A
- RXST N/A
- Industry
- BORR Oil & Gas Production
- RXST Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- BORR Energy
- RXST Health Care
- Exchange
- BORR Nasdaq
- RXST Nasdaq
- Market Cap
- BORR 941.4M
- RXST 1.0B
- IPO Year
- BORR 2019
- RXST 2021
- Fundamental
- Price
- BORR $1.74
- RXST $15.29
- Analyst Decision
- BORR Buy
- RXST Buy
- Analyst Count
- BORR 1
- RXST 10
- Target Price
- BORR $9.00
- RXST $39.30
- AVG Volume (30 Days)
- BORR 5.2M
- RXST 1.1M
- Earning Date
- BORR 05-21-2025
- RXST 05-07-2025
- Dividend Yield
- BORR 4.57%
- RXST N/A
- EPS Growth
- BORR 10.54
- RXST N/A
- EPS
- BORR 0.20
- RXST N/A
- Revenue
- BORR $993,200,000.00
- RXST $148,310,000.00
- Revenue This Year
- BORR $8.35
- RXST $22.25
- Revenue Next Year
- BORR $6.39
- RXST $18.58
- P/E Ratio
- BORR $8.97
- RXST N/A
- Revenue Growth
- BORR 19.15
- RXST 46.70
- 52 Week Low
- BORR $1.55
- RXST $12.53
- 52 Week High
- BORR $7.09
- RXST $61.10
- Technical
- Relative Strength Index (RSI)
- BORR 46.30
- RXST 47.18
- Support Level
- BORR $1.55
- RXST $15.66
- Resistance Level
- BORR $1.90
- RXST $16.48
- Average True Range (ATR)
- BORR 0.10
- RXST 0.89
- MACD
- BORR 0.02
- RXST 0.36
- Stochastic Oscillator
- BORR 40.86
- RXST 65.56
About BORR Borr Drilling Limited
Borr Drilling Ltd is a drilling contractor that owns and operates jack-up rigs of modern and high-specification designs providing drilling services to the oil and gas exploration and production industry. The company operates a fleet of around 16 jack-up drilling rigs. Geographically the activities are carried out through Norway.
About RXST RxSight Inc.
RxSight Inc is a commercial-stage medical technology company dedicated towards improving the vision of patients following cataract surgery. It offers intraocular lens technology that enables doctors to customize and optimize visual acuity for patients after cataract surgery. The company operates and manages its business in one reportable segment, the research and development, manufacture and sale of light adjustable lenses and related capital equipment.